Stada now searching for possible acquisitions in Poland

Stada Arzneimittel AG is currently searching for possible acquisitions in Poland, chief executive Hartmut Retzlaff said in an interview with Financial Times Deutschland.

Retzlaff said Stada will use Serbian generics manufacturer Hemofarm as a platform to expand in eastern Europe.

Last Friday, Stada announced it is making a public offer for Hemofarm for around 485 mln eur.
Source: forbes.com